- Home
- MTEX vs PMN Comparison
MTEX vs PMN Comparison
Compare MTEX & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEX
- PMN
- Stock Information
- Founded
- MTEX 1993
- PMN 2004
- Country
- MTEX United States
- PMN Canada
- Employees
- MTEX N/A
- PMN N/A
- Industry
- MTEX Medicinal Chemicals and Botanical Products
- PMN Pharmaceuticals and Biotechnology
- Sector
- MTEX Health Care
- PMN Health Care
- Exchange
- MTEX Nasdaq
- PMN Nasdaq
- Market Cap
- MTEX 20.0M
- PMN 17.5M
- IPO Year
- MTEX 1999
- PMN N/A
- Fundamental
- Price
- MTEX $10.22
- PMN $0.49
- Analyst Decision
- MTEX
- PMN Strong Buy
- Analyst Count
- MTEX 0
- PMN 2
- Target Price
- MTEX N/A
- PMN $4.50
- AVG Volume (30 Days)
- MTEX 2.4K
- PMN 61.2K
- Earning Date
- MTEX 05-13-2025
- PMN 05-12-2025
- Dividend Yield
- MTEX N/A
- PMN N/A
- EPS Growth
- MTEX N/A
- PMN N/A
- EPS
- MTEX N/A
- PMN N/A
- Revenue
- MTEX $115,036,000.00
- PMN N/A
- Revenue This Year
- MTEX N/A
- PMN N/A
- Revenue Next Year
- MTEX N/A
- PMN N/A
- P/E Ratio
- MTEX N/A
- PMN N/A
- Revenue Growth
- MTEX N/A
- PMN N/A
- 52 Week Low
- MTEX $6.75
- PMN $0.47
- 52 Week High
- MTEX $16.49
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- MTEX 51.33
- PMN 41.73
- Support Level
- MTEX $9.47
- PMN $0.48
- Resistance Level
- MTEX $11.65
- PMN $0.61
- Average True Range (ATR)
- MTEX 0.48
- PMN 0.06
- MACD
- MTEX -0.04
- PMN 0.00
- Stochastic Oscillator
- MTEX 43.53
- PMN 14.29
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.